Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

THOUSANDS of Brits with bladder cancer could survive for twice as long after a new treatment was given the green light to be ...

New trial results reveal enfortumab vedotin and pembrolizumab significantly improve survival for muscle-invasive bladder ...

A significant breakthrough in advanced bladder cancer treatment has been approved for use on the NHS, offering renewed hope to patients and potentially doubling survival times. The innovative ...

New trial results reveal that pembrolizumab and enfortumab vedotin significantly enhance survival rates for muscle-invasive ...

Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...

NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease.

NHS approves new enfortumab vedotin and pembrolizumab combo for advanced bladder cancer, doubling survival rates and offering ...

A new treatment for advanced bladder cancer that doubles life expectancy is set for use on the NHS. Experts said it was the most significant advancement in bladder cancer treatment since the 1980s.

The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 ...

The KEYNOTE-905 study is ongoing and will evaluate other endpoints including EFS, OS, and pCR rate for neoadjuvant and adjuvant pembrolizumab vs surgery alone.